Current Headwinds to Help Shape M&A Contours for Indian Pharma

"From an M&A perspective, the current regulatory or pricing related challenges will have a marginal impact on the pharma companies being highly diversified geographically. Consolidation in the industry is bound to happen and at a more global level -especially outbound M&A,"

Vrinda Mathur
Partner, Grant Thornton India LLP

This article appeared in Economic Times on 22nd June, 2017.